Valion Bio Scales Up Entolimod Biodefense Platform with U.S. Government Engagement, Domestic Manufacturing, and Oncology Expansion 1234567
Valion Bio Advances Biodefense and Immunology Platform: Key ...
Sign in to continue:
Valion Bio Advances Biodefense and Immunology Platform: Key ...
Virtu Financial Announces Preliminary Q2 2026 Results and La...
Cingulate Inc. Announces Key Shareholder Approvals and Major...
RE/MAX Holdings, Inc. 8-K Filing: Key Details for Investors ...
Fastenal Company Reports Robust Second Quarter 2026 Results ...
Inhibikase Therapeutics Raises \$50 Million in ATM Offering ...
Yarrow Bioscience and VYNE Therapeutics Announce Transformat...
Diodes Incorporated to Acquire ElevATE Semiconductor in \$25...
Runway Growth Finance Corp. (Nasdaq: RWAY) Delivers Q2 2026 ...
Syndax Pharmaceuticals Unveils New Pipeline Assets and Provi...